Dr. Ronald Bleday, MD

Dr. Bleday practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Bleday's NPI, 1841257466, was assigned on April 27, 2006. Dr. Bleday graduated from McGill University Faculty of Medicine in 1982. Dr. Bleday's Massachusetts license number on file is 53730.

Dr. Bleday's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Bleday's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Bleday is also affiliated with Brigham and Women's Faulkner Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Bleday to 1 more home health agency, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bleday practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Bleday's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Bleday is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Bleday's licenses on file in 2 states: Massachusetts and New Hampshire.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Bleday treats.

CMS data shows 245 Medicare services from Dr. Bleday across 9 procedure codes in 2024, for 185 Medicare patients. Medicare paid $24,535 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Bleday in 2024. The largest group is 65 to 74, with 97 patients. 73% of them have high cholesterol, and 63% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bleday's median patient age at 66, with 50% women.

In 2024, Dr. Bleday wrote 20 Medicare Part D claims for 15 patients. 100% of them were for generic drugs. They cover 2 drugs, with $122 in total drug cost. In 2021, CMS named 86 claims across 2 drugs.

Dr. Bleday accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bleday as offering telehealth. CMS counts 60 procedures of colonoscopy by Dr. Bleday, more than 67% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 118 papers to Dr. Bleday, published from 2004 to 2025. 2019 was the busiest year, with 20. The most frequent topics are Rectal Neoplasms, Postoperative Complications and Adenocarcinoma. Dr. Bleday has published most often in Dis Colon Rectum. Dr. Bleday's most frequent co-authors are Jennifer Lynn Irani, MD, Nelya Melnitchouk, MD and Joel Edward Goldberg, MD.

Dmand AI links Dr. Bleday to 1 clinical trial. Conditions studied include Rectal Neoplasms and Rectal Diseases.

CMS Open Payments shows 24 general payments to Dr. Bleday from 8 drug and device companies from 2016 to 2025. Education make up the largest share, 42% of the total. Intuitive Surgical, Inc. paid the most, $3,561.

Dmand AI lists 4 awards for Dr. Bleday, most recently Top Doctors in 2023.

Dr. Bleday graduated from McGill University Faculty of Medicine in 1982. Dr. Bleday is a member of ACS and ASCRS.

Dr. Bleday is in network with 16 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.